Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.29 USD | -1.74% | -15.59% | +41.62% |
Jun. 04 | Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target | MT |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.62% | 521M | |
+17.73% | 124B | |
+16.88% | 111B | |
-9.04% | 23.17B | |
+5.21% | 22.94B | |
-38.15% | 17.42B | |
-7.75% | 17.42B | |
-14.78% | 16.9B | |
+3.42% | 13.71B | |
+29.63% | 11.82B |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.
- Mizuho Securities Adjusts Selecta Biosciences Price Target to $4 From $5, Maintains Buy Rating